Private company

U.S. Stem Cell, Inc.

American commercial physical and biological research services company2

In its 2023 annual report the company says: “We are a biotechnology company focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of disease and injury. We are also a regenerative medicine company specializing in physician/veterinary training and certification and stem cell products.”43 It is headquartered in Sunrise, United States.2

Last updated Oct 20, 2026.

Overview

  • IndustryServices-Commercial Physical & Biological Research2
  • HeadquartersSunrise, United States2
  • Incorporated inFL3
  • Business address1560 Sawgrass Corporate Pkwy, 4Th Floor, Sunrise, Fl 333233
  • Filer categoryNon-accelerated filer, Smaller reporting company3
  • Legal formProfit Corporation2
  • LEI549300BYV51UWQXOKZ832
  • StatusActive2
  • LEI statusLapsed (not renewed)2
  • Registered addressC/O Emas, Joseph, 33154 Surfside, United States2
  • Registered withFlorida Division of Corporations, P990000718152

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2022

71.0%Gross margin4
-2096.9%Operating margin4
-3483.2%Net margin4
-59.1%Revenue growth, 20224

Where the money goes

Where each dollar of revenue went, fiscal 2022

  • Cost of revenue1¢$23.8K
  • Selling, general and admin71¢$1.8M
  • Interest28¢$690.0K

Out of $82.0K in revenue.4 The company lost money this year.

Financial statements

Revenue567894$82.0K in 2022−97% since 2016
0$2.0M$4.0M$6.0M$8.0M2016: $3.1M$3.1M20162017: $5.5M$5.5M2017+79%2018: $6.7M$6.7M2018+21%2019: $3.1M$3.1M2019−54%2020: $277.1K$277.1K2020−91%2021: $200.7K$200.7K2021−28%2022: $82.0K$82.0K2022−59%
Gross profit567894$58.3K in 2022−97% since 2016
0$2.0M$4.0M$6.0M2016: $2.1M$2.1M20162017: $3.6M$3.6M2017+72%2018: $4.6M$4.6M2018+26%2019: $1.7M$1.7M2019−62%2020: $213.0K$213.0K2020−88%2021: $148.7K$148.7K2021−30%2022: $58.3K$58.3K2022−61%
Operating income567894-$1.7M in 2022+48% since 2016
-$4.0M-$3.0M-$2.0M-$1.0M02016: -$1.2M-$1.2M20162017: -$804.7K-$804.7K2017−31%2018: -$1.1M-$1.1M2018+36%2019: -$3.4M-$3.4M2019+211%2020: -$2.4M-$2.4M2020−30%2021: -$2.1M-$2.1M2021−11%2022: -$1.7M-$1.7M2022−19%
Net income567894-$2.9M in 2022+38% since 2016
-$4.0M-$3.0M-$2.0M-$1.0M02016: -$2.1M-$2.1M20162017: -$3.5M-$3.5M2017+68%2018: -$2.2M-$2.2M2018−38%2019: -$3.8M-$3.8M2019+78%2020: -$2.9M-$2.9M2020−25%2021: -$3.3M-$3.3M2021+14%2022: -$2.9M-$2.9M2022−13%
Fiscal year2016201720182019202020212022
Revenue$3.1M5$5.5M6$6.7M7$3.1M8$277.1K9$200.7K4$82.0K4
Cost of revenue$972.0K5$1.9M6$2.1M7$1.3M8$64.1K9$52.0K4$23.8K4
Gross profit$2.1M5$3.6M6$4.6M7$1.7M8$213.0K9$148.7K4$58.3K4
Research and development$9195$6.6K6$5.4K7$2638$08$09
Selling, general and admin$3.3M5$4.4M6$5.7M7$4.5M8$2.6M9$2.3M4$1.8M4
Operating expenses$2.3M4$1.8M4
Operating income-$1.2M5-$804.7K6-$1.1M7-$3.4M8-$2.4M9-$2.1M4-$1.7M4
Interest$1.2M5$642.1K6$1.4M7$981.0K8$488.4K9$1.0M4$690.0K4
Income before tax-$3.3M4-$2.9M4
Income tax$05$06$07$08$09$04$04
Net income-$2.1M5-$3.5M6-$2.2M7-$3.8M8-$2.9M9-$3.3M4-$2.9M4

Compare U.S. Stem Cell, Inc. with another company

What it owns

What U.S. Stem Cell, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Furniture and fixtures$5.6K9 Dec 31, 2021$5.6K9 Dec 31, 20200%
Computer equipment and software$1.8K9 Dec 31, 2021$1.8K9 Dec 31, 20200%
Property and equipment, before depreciation$7.4K9 Dec 31, 2021$7.4K9 Dec 31, 20200%
Accumulated depreciation$7.4K9 Dec 31, 2021$7.4K9 Dec 31, 20200%
Property and equipment, net$09 Dec 31, 2021$09 Dec 31, 2020

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$5.1K4 Dec 31, 2022$39.4K4 Dec 31, 2021−87.0%

Inventory

ItemLatestA year beforeChange
Inventory, total$9804 Dec 31, 2022$3934 Dec 31, 2021+149.4%

Leadership

Who has led U.S. Stem Cell, Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. William M. Pinon2007
  2. Howard J. Leonhardt2009
  3. Karl Groth2010

Chair

  1. Howard J. Leonhardt2007–2009

President

  1. William M. Pinon2007

Chief financial officer

  1. William H. Kline2007
  2. Peggy A. Farley2010

Chief operating officer

  1. Peggy A. Farley2010
  2. Catherine Sulawske-Guck2011
2010201520202025
Board members and other officers (23)

Former names

  • BIOHEART, INC.Feb 13, 2007 to Nov 2, 20153

Timeline

  1. Mar 9, 20228-K Other events41
  2. Mar 9, 20228-K Other events42
  3. Feb 18, 2010New chief executive Karl Groth becomes CEO13
  4. May 27, 2009New chief executive Howard J. Leonhardt becomes CEO14
  5. Oct 2, 2007New chief executive William M. Pinon becomes CEO15
  6. Aug 12, 1999Founded U.S. Stem Cell, Inc. is founded2

Filings

19 filings to the SEC since October 2021: 3 annual reports, 4 quarterly reports, 2 major events, 3 insider forms, 7 other. The latest 19:

  1. May 15, 2023NT 10-Q EDGAR
  2. Apr 14, 202310-K EDGAR
  3. Mar 31, 2023NT 10-K EDGAR
  4. Nov 9, 202210-Q EDGAR
  5. Aug 22, 202210-Q EDGAR
  6. Aug 15, 2022NT 10-Q EDGAR
  7. Aug 1, 2022UPLOAD EDGAR
  8. Jul 27, 2022CORRESP EDGAR
  9. Jul 8, 202210-K/A EDGAR
  10. Jun 27, 2022UPLOAD EDGAR
  11. May 23, 202210-Q EDGAR
  12. May 16, 2022NT 10-Q EDGAR
  13. Apr 29, 20224 EDGAR
  14. Mar 31, 202210-K EDGAR
  15. Mar 25, 20224 EDGAR
  16. Mar 9, 20228-K/A EDGAR
  17. Mar 9, 20228-K EDGAR
  18. Mar 4, 20224 EDGAR
  19. Nov 9, 202110-Q EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

SEC filer profile

How U.S. Stem Cell, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARU.S. Stem Cell, Inc.1
  • CIK0001388319
  • Employer ID (EIN)65-09459671
  • Filer statusNon-accelerated filer<br>smaller reporting company1
  • Incorporated inFlorida1
  • Fiscal year endsDecember 311
  • Industry code (SIC)8731 Services-Commercial Physical & Biological Research1
  • Business address1560 Sawgrass Corporate Pkwy, 4Th Floor, Sunrise, FL 333231
  • Phone954-835-15001
  • Shares outstanding641,507,317 as of Apr 14, 20234
  • Public float$2.4M as of Jun 30, 20224
  • On EDGAR sinceFeb 13, 20071
  • Filings532 in all: 4 (170), 8-K (101), 10-Q (46), UPLOAD (25), 3 (24), CORRESP (24), 10-K (16), D (10)1
    All 39 form types

    S-1/A (10), SC 13G (9), SC 13G/A (9), 10-K/A (8), 4/A (7), NT 10-Q (7), POS AM (7), EFFECT (6), NT 10-K (6), 5 (5), PRER14C (5), DEF 14C (4), PRE 14C (4), S-1 (4), 424B3 (3), 10-Q/A (2), 8-K/A (2), DEF 14A (2), FWP (2), S-8 (2), S-8 POS (2), 1-A (1), 25-NSE (1), 253G2 (1), 424B4 (1), 8-A12B (1), AW (1), CERTNAS (1), PRE 14A (1), QUALIF (1), SC 13D (1)

  • Latest filingsAnnual report (10-K) Apr 14, 2023
    Quarterly report (10-Q) Nov 9, 2022
    Proxy statement (DEF 14A) Dec 19, 2014
    Latest 8-K (8-K) Mar 9, 2022

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
    SEC EDGAROther events
  42. 42
    SEC EDGAROther events
  43. 43